Pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in mechanically ventilated patients after primary lung transplantation

Trial Profile

Pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in mechanically ventilated patients after primary lung transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2015

At a glance

  • Drugs Solnatide (Primary)
  • Indications Reperfusion injury
  • Focus Therapeutic Use
  • Sponsors APEPTICO Forschung und Entwicklung
  • Most Recent Events

    • 23 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 06 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 07 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top